In the cardiovascular system the drugs effects the conditions like  Peripheral vascular tone ,Inotropic state of the heart ,Chronotropic state of the heart Clinically these drugs are used in ,Acute ischemic heart disease,Acute and chronic heart failure,Shock (especially cardiogenic),Cardiac arrest. when the drugs that are used during the cardiac treatment may give positive results when given in the correct dosage and gives negative results if there is slight variation in the dose and its frequency.Keywords: significant effects, cardiac arrest, dose adjustment
Heart failure remains a major therapeutic problem with a poor prognosis despite therapy with digital...
The effects of dobutamine and intravenous milrinone on systemic hemodynamics, coronary blood flow an...
The hemodynamic effects of CI-914, a phosphodiesterase inhibitor, were studied in 12 patients with l...
SUMMARY Amrinone, a positive inotropic-vasodilator agent, was administered to anaesthetised dogs in ...
effect, congestive heart failure. Cardiac phosphodiesterase III (PDE) inhibitors derived from pyridi...
Heart failure (HF) and coronary insufficiency are common amongst surgical and critical care patients...
AbstractBecause cardiac contractility is impaired in chronic heart failure, many pharmacologic agent...
Abstract Heart failure is one of the major problems related to heart diseases in the modern era. Mul...
Inotropic agents are administered to improve cardiac output and peripheral perfusion in patients wit...
Acute Heart Failure Syndromes are defined as the rapid progression, or de novo presentation, of hear...
WE STUDIED IN PATIENTS (PTS) WITH ACUTE MYOCARDIAL INFARCION AND/OR UNSTABLE ANGINA THE ANTIARRHYT...
This report describes various old and new positive inotropic drugs with respect to their mechanisms ...
Control of cardiovascular (CV) risk factors, particularly hypertension, is still unsatisfactory, res...
Background: Myocardial failure and dysfunction is not uncommon during critical illness and following...
We compared the effects of the phosphodiesterase inhibitor amrinone, the beta-adrenergic partial ago...
Heart failure remains a major therapeutic problem with a poor prognosis despite therapy with digital...
The effects of dobutamine and intravenous milrinone on systemic hemodynamics, coronary blood flow an...
The hemodynamic effects of CI-914, a phosphodiesterase inhibitor, were studied in 12 patients with l...
SUMMARY Amrinone, a positive inotropic-vasodilator agent, was administered to anaesthetised dogs in ...
effect, congestive heart failure. Cardiac phosphodiesterase III (PDE) inhibitors derived from pyridi...
Heart failure (HF) and coronary insufficiency are common amongst surgical and critical care patients...
AbstractBecause cardiac contractility is impaired in chronic heart failure, many pharmacologic agent...
Abstract Heart failure is one of the major problems related to heart diseases in the modern era. Mul...
Inotropic agents are administered to improve cardiac output and peripheral perfusion in patients wit...
Acute Heart Failure Syndromes are defined as the rapid progression, or de novo presentation, of hear...
WE STUDIED IN PATIENTS (PTS) WITH ACUTE MYOCARDIAL INFARCION AND/OR UNSTABLE ANGINA THE ANTIARRHYT...
This report describes various old and new positive inotropic drugs with respect to their mechanisms ...
Control of cardiovascular (CV) risk factors, particularly hypertension, is still unsatisfactory, res...
Background: Myocardial failure and dysfunction is not uncommon during critical illness and following...
We compared the effects of the phosphodiesterase inhibitor amrinone, the beta-adrenergic partial ago...
Heart failure remains a major therapeutic problem with a poor prognosis despite therapy with digital...
The effects of dobutamine and intravenous milrinone on systemic hemodynamics, coronary blood flow an...
The hemodynamic effects of CI-914, a phosphodiesterase inhibitor, were studied in 12 patients with l...